title: How KDIGO will (or will not) influence the management of hyperphosphatemia.
authors.affiliation: Division of Nephrology, Salem Veterans Affairs Medical Center, Salem, Virginia 24153, USA. csaba.kovesdy@va.gov
authors.forename: Csaba P
authors.initials: CP
authors.lastname: Kovesdy
mesh_terms: D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000150:complications* / Q000453:epidemiology / Q000517:prevention & control; D015314:Dialysis Solutions / Q000592:standards*; D014943:Global Health; D006801:Humans; D054559:Hyperphosphatemia / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D015994:Incidence; D007676:Kidney Failure, Chronic / Q000628:therapy*; D010758:Phosphorus / Q000097:blood; D017410:Practice Guidelines as Topic; D006435:Renal Dialysis / Q000009:adverse effects*
chemical_list: D015314:Dialysis Solutions; D010758:Phosphorus